Literature DB >> 2126252

Production of interferon-gamma and tumour necrosis factor-alpha by human T-cell clones expressing different forms of the gamma delta receptor.

S E Christmas1, A Meager.   

Abstract

Panels of human T-cell clones bearing the gamma delta T-cell receptor (TcR) were obtained from peripheral blood and decidual tissue and maintained in the presence of interleukin-2 (IL-2). TcR V gamma and V delta gene expression was determined in 40 TcR delta 1+ clones using the gamma delta T-cell subset markers Ti gamma A and delta TCS1, in conjunction with Southern blot analysis using TcR J gamma and J delta probes. gamma delta T-cell clones, together with control alpha beta T-cell clones derived from the same lymphocyte populations, were stimulated with phytohaemagglutinin (PHA) and their ability to produce interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) tested using specific ELISA. Many clones representative of the major peripheral V gamma 9/V delta 2J1 subset produced high amounts of both cytokines and mean levels were not significantly different from those produced by alpha beta T-cell clones. Panels of clones expressing V gamma 9 and V delta 2J1 produced significantly higher levels of TNF-alpha than clones not expressing V delta 2J1 and those expressing V delta 1J1. There was no relationship between levels of IFN-gamma and TNF-alpha produced by individual gamma delta T-cell clones and also no relationship between their non-major histocompatibility complex (MHC)-restricted cytotoxic activity and levels of either cytokine. There was a significant tendency for gamma delta T-cell clones to produce more TNF-alpha than IFN-gamma in comparison to alpha beta T-cell clones. The significance of these findings is discussed in the light of the reported differences in distribution in vivo of V delta 1J1+ and V delta 2J1+ cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2126252      PMCID: PMC1384867     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  38 in total

Review 1.  Lymphoepithelial interactions in the mucosal immune system.

Authors:  P Brandtzaeg; L M Sollid; P S Thrane; D Kvale; K Bjerke; H Scott; K Kett; T O Rognum
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

2.  Characterization of human peripheral lymphocytes expressing the CD3-gamma/delta complex with anti-receptor monoclonal antibodies.

Authors:  F Faure; S Jitsukawa; F Triebel; T Hercend
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

3.  Rearrangements to the JP1, JP and JP2 segments in the human T-cell rearranging gamma gene (TRG gamma) locus.

Authors:  S Huck; M P Lefranc
Journal:  FEBS Lett       Date:  1987-11-30       Impact factor: 4.124

4.  Phenotypic and functional characterization of human T cell clones.

Authors:  S S Patel; A D Duby; D L Thiele; P E Lipsky
Journal:  J Immunol       Date:  1988-12-01       Impact factor: 5.422

5.  Differential secretion of tumor necrosis factor-alpha and granulocyte/macrophage colony-stimulating factors but not interferon-gamma from CD4+ compared to CD8+ human T cell clones.

Authors:  G Pawelec; K Schaudt; A Rehbein; F W Busch
Journal:  Eur J Immunol       Date:  1989-01       Impact factor: 5.532

6.  Human T cells from autoimmune and normal individuals can produce tumor necrosis factor.

Authors:  M Turner; M Londei; M Feldmann
Journal:  Eur J Immunol       Date:  1987-12       Impact factor: 5.532

7.  Diversity and organization of human T cell receptor delta variable gene segments.

Authors:  S Hata; M Clabby; P Devlin; H Spits; J E De Vries; M S Krangel
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

8.  Antigen recognition by human T cell receptor gamma-positive lymphocytes. Specific lysis of allogeneic cells after activation in mixed lymphocyte culture.

Authors:  E Ciccone; O Viale; C Bottino; D Pende; N Migone; G Casorati; G Tambussi; A Moretta; L Moretta
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

9.  Characterization of a third form of the human T cell receptor gamma/delta.

Authors:  F Hochstenbach; C Parker; J McLean; V Gieselmann; H Band; I Bank; L Chess; H Spits; J L Strominger; J G Seidman
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

10.  Two subsets of human T lymphocytes expressing gamma/delta antigen receptor are identifiable by monoclonal antibodies directed to two distinct molecular forms of the receptor.

Authors:  C Bottino; G Tambussi; S Ferrini; E Ciccone; P Varese; M C Mingari; L Moretta; A Moretta
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

View more
  15 in total

1.  Functional phenotype of transformed human alphabeta and gammadelta T cells determined by different subgroup C strains of herpesvirus Saimiri.

Authors:  H Fickenscher; C Bökel; A Knappe; B Biesinger; E Meinl; B Fleischer; B Fleckenstein; B M Bröker
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  Cerebral malaria in mice: interleukin-2 treatment induces accumulation of gammadelta T cells in the brain and alters resistant mice to susceptible-like phenotype.

Authors:  A Haque; H Echchannaoui; R Seguin; J Schwartzman; L H Kasper; S Haque
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

3.  CDR3δ -grafted γ9δ2T cells mediate effective antitumor reactivity.

Authors:  Hui Zhao; Xueyan Xi; Lianxian Cui; Wei He
Journal:  Cell Mol Immunol       Date:  2011-09-12       Impact factor: 11.530

4.  Oral carriage of Candida albicans in murine AIDS.

Authors:  N Deslauriers; L Côté; S Montplaisir; L de Repentigny
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

5.  Impact of age, gender, and race on circulating γδ T cells.

Authors:  Cristiana Cairo; Cheryl L Armstrong; Jean Saville Cummings; Carl O Deetz; Ming Tan; Changwan Lu; Charles E Davis; C David Pauza
Journal:  Hum Immunol       Date:  2010-06-30       Impact factor: 2.850

6.  Predominant activation and expansion of V gamma 9-bearing gamma delta T cells in vivo as well as in vitro in Salmonella infection.

Authors:  T Hara; Y Mizuno; K Takaki; H Takada; H Akeda; T Aoki; M Nagata; K Ueda; G Matsuzaki; Y Yoshikai
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

7.  Immunoglobulin G1 (IgG1) and IgG3 antibodies are markers of progressive disease in leprosy.

Authors:  R Hussain; A Kifayet; T J Chiang
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

8.  IgG subclass antibody to Mycobacterium leprae 18,000 MW antigen is restricted to IgG1 and IgG3 in leprosy.

Authors:  R Hussain; H M Dockrell; T J Chiang
Journal:  Immunology       Date:  1994-11       Impact factor: 7.397

9.  Respiratory syncytial virus infection suppresses IFN-gamma production of gammadelta T cells.

Authors:  M Aoyagi; N Shimojo; K Sekine; T Nishimuta; Y Kohno
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

10.  Recognition of Mycobacterium leprae recombinant 18,000 MW epitopes by IgG subclasses in leprosy.

Authors:  R Hussain; B Menz; H M Dockrell; T J Chiang
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.